Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Agarwala

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Current Treatment Options in Oncology|June 12, 2002
Intermediate- and high-risk melanomaSanjiv S Agarwala
Melanoma Management|September 8, 2018
Rose Bengal for melanoma treatment: will it translate to the clinic?Sanjiv S Agarwala
Hematology/Oncology Clinics of North America|September 24, 1999
Adjuvant chemotherapy in head and neck cancerS S Agarwala
Melanoma Research|December 3, 2009
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanomaSanjiv S Agarwala
Expert Review of Anticancer Therapy|December 20, 2012
An update on pegylated IFN-α2b for the adjuvant treatment of melanomaSanjiv S Agarwala
Oncology (Williston Park, N.Y.)|May 19, 2016
The Role of Intralesional Therapies in MelanomaSanjiv S Agarwala
Onkologie|December 18, 2004
Relevance and necessity of studies on second-line chemotherapy in melanomaSanjiv S Agarwala
Expert Review of Anticancer Therapy|May 19, 2009
Current systemic therapy for metastatic melanomaSanjiv S Agarwala
Seminars in Oncology|November 25, 2015
The Expanding Role of Immunotherapy in Melanoma--IntroductionSanjiv S Agarwala
Current Opinion in Oncology|January 29, 2015
Intralesional therapy for advanced melanoma: promise and limitationSanjiv S Agarwala
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Current Treatment Options in Oncology|June 12, 2002
Intermediate- and high-risk melanomaSanjiv S Agarwala
Melanoma Management|September 8, 2018
Rose Bengal for melanoma treatment: will it translate to the clinic?Sanjiv S Agarwala
Hematology/Oncology Clinics of North America|September 24, 1999
Adjuvant chemotherapy in head and neck cancerS S Agarwala
Melanoma Research|December 3, 2009
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanomaSanjiv S Agarwala
Expert Review of Anticancer Therapy|December 20, 2012
An update on pegylated IFN-α2b for the adjuvant treatment of melanomaSanjiv S Agarwala
Oncology (Williston Park, N.Y.)|May 19, 2016
The Role of Intralesional Therapies in MelanomaSanjiv S Agarwala
Onkologie|December 18, 2004
Relevance and necessity of studies on second-line chemotherapy in melanomaSanjiv S Agarwala
Expert Review of Anticancer Therapy|May 19, 2009
Current systemic therapy for metastatic melanomaSanjiv S Agarwala
Seminars in Oncology|November 25, 2015
The Expanding Role of Immunotherapy in Melanoma--IntroductionSanjiv S Agarwala
Current Opinion in Oncology|January 29, 2015
Intralesional therapy for advanced melanoma: promise and limitationSanjiv S Agarwala
Pageof 26